FDA scientists raise safety and efficacy concerns over peptides backed by RFK Jr.

Internal FDA documents reveal that agency scientists have flagged a lack of solid evidence for the efficacy and safety of peptides — trendy molecules endorsed by Health Secretary RFK Jr. Despite these concerns, an FDA advisory panel is scheduled later this month to consider easing restrictions on access to peptides.